MA3-914

antibody from Invitrogen Antibodies

Targeting: ATP2B4 ATP2B2, MXRA1, PMCA4

Provider product page for MA3-914

Western blot

Antibody data

Antibody Data
Antigen structure
References [83]
Comments [0]
Validations
Western blot [1]
Immunocytochemistry [3]
Immunohistochemistry [3]
Flow cytometry [2]
Other assay [19]

Submit

Product number: MA3-914 - Provider product page
Provider: Invitrogen Antibodies
Product name: PMCA ATPase Monoclonal Antibody (5F10)
Antibody type: Monoclonal
Antigen: Purifed from natural sources
Description: MA3-914 detects calcium pump of the plasma membrane (PMCA) ATPase from amphibian, canine, chicken, feline, human, mouse, sheep, primate, rabbit, and rat tissues. This antibody detects all four known isoforms of the PMCA ATPase.
Antibody clone number: 5F10
Concentration: 1 mg/mL

ATP2B4 protein structure - MA3-914 shown in red.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescent analysis of PMCA ATPase using Anti-PMCA ATPase Monoclonal Antibody (5F10) (Product # MA3-914) shows staining in C6 Cells. PMCA ATPase staining (green), F-Actin staining with Phalloidin (red) and nuclei with DAPI (blue) is shown. Cells were grown on chamber slides and fixed with formaldehyde prior to staining. Cells were probed without (control) or with or an antibody recognizing PMCA ATPase (Product # MA3-914) at a dilution of 1:200 over night at 4°C, washed with PBS and incubated with a DyLight-488 conjugated secondary antibody (Product # 35503, Goat Anti-Mouse). Images were taken at 60X magnification.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescent analysis of PMCA ATPase using Anti-PMCA ATPase Monoclonal Antibody (5F10) (Product # MA3-914) shows staining in Hela Cells. PMCA ATPase staining (green), F-Actin staining with Phalloidin (red) and nuclei with DAPI (blue) is shown. Cells were grown on chamber slides and fixed with formaldehyde prior to staining. Cells were probed without (control) or with or an antibody recognizing PMCA ATPase (Product # MA3-914) at a dilution of 1:100 over night at 4°C, washed with PBS and incubated with a DyLight-488 conjugated secondary antibody (Product # 35503, Goat Anti-Mouse). Images were taken at 60X magnification.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescent analysis of PMCA ATPase using Anti-PMCA ATPase Monoclonal Antibody (5F10) (Product # MA3-914) shows staining in U251 Cells. PMCA ATPase staining (green), F-Actin staining with Phalloidin (red) and nuclei with DAPI (blue) is shown. Cells were grown on chamber slides and fixed with formaldehyde prior to staining. Cells were probed without (control) or with or an antibody recognizing PMCA ATPase (Product # MA3-914) at a dilution of 1:200 over night at 4°C, washed with PBS and incubated with a DyLight-488 conjugated secondary antibody (Product # 35503, Goat Anti-Mouse). Images were taken at 60X magnification.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunohistochemistry was performed on normal deparaffinized Human brain tissue tissues. To expose target proteins, heat induced antigen retrieval was performed using 10mM sodium citrate (pH6.0) buffer, microwaved for 8-15 minutes. Following antigen retrieval tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature. Tissues were then probed at a dilution of 1:200 with a mouse monoclonal antibody recognizing PMCA ATPase (Product # MA3-914) or without primary antibody (negative control) overnight at 4°C in a humidified chamber. Tissues were washed extensively with PBST and endogenous peroxidase activity was quenched with a peroxidase suppressor. Detection was performed using a biotin-conjugated secondary antibody and SA-HRP, followed by colorimetric detection using DAB. Tissues were counterstained with hematoxylin and prepped for mounting.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunohistochemistry was performed on cancer biopsies of deparaffinized Human colon carcinoma tissues. To expose target proteins, heat induced antigen retrieval was performed using 10mM sodium citrate (pH6.0) buffer, microwaved for 8-15 minutes. Following antigen retrieval tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature. Tissues were then probed at a dilution of 1:100 with a mouse monoclonal antibody recognizing PMCA ATPase (Product # MA3-914) or without primary antibody (negative control) overnight at 4°C in a humidified chamber. Tissues were washed extensively with PBST and endogenous peroxidase activity was quenched with a peroxidase suppressor. Detection was performed using a biotin-conjugated secondary antibody and SA-HRP, followed by colorimetric detection using DAB. Tissues were counterstained with hematoxylin and prepped for mounting.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunohistochemistry was performed on normal deparaffinized Human tonsil tissue tissues. To expose target proteins, heat induced antigen retrieval was performed using 10mM sodium citrate (pH6.0) buffer, microwaved for 8-15 minutes. Following antigen retrieval tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature. Tissues were then probed at a dilution of 1:200 with a mouse monoclonal antibody recognizing PMCA ATPase (Product # MA3-914) or without primary antibody (negative control) overnight at 4°C in a humidified chamber. Tissues were washed extensively with PBST and endogenous peroxidase activity was quenched with a peroxidase suppressor. Detection was performed using a biotin-conjugated secondary antibody and SA-HRP, followed by colorimetric detection using DAB. Tissues were counterstained with hematoxylin and prepped for mounting.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 4 Western blot analysis of PMCA protein in synaptosomal membranes. The protein level was determined by immunoblotting (A) using 5F10 antibody recognizing all PMCA isoforms as well as isoform-specific antibodies. The intensity of bands was quantitated by densitometry (B) . The results are presented as AU obtained after normalization to endogenous Na + /K + -ATPase level. Representative blots are shown. Arrows indicate bands taken for quantitative analysis. * P < 0.05 ketamine treated vs. saline, n = 5. CB, cerebellum; H, hippocampus; ST, striatum.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 1 Expression of NCX1 and other Ca handling proteins in atrial-specific NCX1 knockout mice. A . Immunoblot (top) of mouse atrial (A) and ventricular (V) homogenate using an antibody to NCX1 in wildtype control (C) and atrial-specific NCX1 KO mice. There is complete absence of NCX1 protein in the immunoblot. The new band in the KO lanes at ~110 kDa represents nonfunctional NCX in KO atria after excision of exon 11 by Cre recombinase [13] . Ventricular expression of NCX1 is unaffected in atrial-specific KO mice. The bottom panel shows immunofluorescence of isolated SAN node myocytes from control (C) and KO hearts. Myocytes were co-immunolabled with antibodies against HCN4 and NCX1. Both control and KO SAN cells stained positive for HCN4, but only control SAN cells showed staining of NCX at the membrane. B . Immunoblots of sarcoendoplasmic reticulum Ca ATPase (SERCA), plasma membrane Ca pump (PMCA; the lower band at 72 kDa represents an active proteolytic fragment), and dihydropyridine receptor (DHPR) in control (C) and NCX1 KO atria. Note the reduction in SERCA and the increase in PMCA and DHPR in KO.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 4 Western blot analysis of PMCA protein in synaptosomal membranes. The protein level was determined by immunoblotting (A) using 5F10 antibody recognizing all PMCA isoforms as well as isoform-specific antibodies. The intensity of bands was quantitated by densitometry (B) . The results are presented as AU obtained after normalization to endogenous Na + /K + -ATPase level. Representative blots are shown. Arrows indicate bands taken for quantitative analysis. * P < 0.05 ketamine treated vs. saline, n = 5. CB, cerebellum; H, hippocampus; ST, striatum.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 7 Lamination patterns and differential compartmentation of pan-plasma membrane Ca 2+ ATPase and Na + -Ca 2+ exchanger isoform 1 in rod spherules and cone pedicles. A : Confocal image of retina immunolabeled for pan-plasma membrane Ca 2+ ATPase (pan-PMCA). The double white arrowheads identify strongly labeled PMCA bands in each IPL sublamina. The scale bar applies to A , D and represents 40 mum. B - D : PMCA preferentially labels rod spherules. OPL double labeled with markers for PMCA (green), vesicular glutamate transporter 1 (VGluT1: blue) and/or M-cone arrestin (M-CAr: red). Scale bar equal 20 mum. B : VGluT1, which labels photoreceptor terminals and M-CAr, which labels cones, colocalize in the OPL. This reveals the large dome-shaped cone pedicles (purple pixels) and some cone axons (white arrowheads). C : This high magnification image shows the horseshoe-like appearance of the PMCA-positive rod spherules. In contrast, the retina double labeled with PMCA and M-CAr shows that cone pedicles stain weakly and diffusely for PMCA, except for a discrete band at the top of the pedicle (white arrowheads: yellow pixels). D : A retina double labeled with PMCA and VGluT1 confirms that PMCA extensively labels rod spherules, but only sparsely labels cone pedicles (white arrowheads). E : PKCalpha-positive rod bipolar cells (red) are pan-PMCA-negative (green), although they are in close apposition around the rod spherules (yellow pixels). The scale bar represents 20 mum. F : Retinal

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 8 NCX1 localizes to ribbon synaptic units of cone pedicles and mitochondria closely associate with PMCA in photoreceptor terminals. A : NCX1-positive cone pedicles (red) and VGluT1 (blue) colocalize in the proximal ONL (white arrowheads: purple pixels). B : Synaptotagmin 1 (green) labels photoreceptor synaptic vesicles. Small NCX1- and synaptotagmin 1-positive puncta colocalize in rod spherules (white arrows: yellow pixels), while larger colocalized clusters are present in cone pedicles (white arrowheads: yellow-orange pixels). Scale bar equal 20 mum. C : Kinesin KIF3A (green) labels photoreceptor ribbons and docked synaptic vesicles. The kinesin-labeled rod spherules have an arc-shaped appearance and colocalize with diffusely located NCX1 (small yellow puncta). In contrast, cone pedicles have large clusters of double labeled NCX1- and kinesin-positive puncta (white arrows: yellow-orange pixels). Scale bar equal 20 mum. D - F : Mitochondria cluster away from the active zone in cone pedicles. Scale for D and E equal 20 mum and for F equal 10 mum. D : NCX1 (red) and PNA (blue) colocalize in cone pedicles (purple pixels). E : Triple labeling with NCX1, PNA and COX IV (green) reveals that the cone pedicles (white ellipsoids) contain multiple mitochondria that are located away from the ribbon synaptic unit. F : Higher magnification image of the same six pedicles in E reveals the COX IV and NCX1 colabeling (white arrowheads) and the distance of the COX IV-positive mitochondr

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure EV1 Behavioral characterization of wt mice following striatal infusion of the high dose of cholesterol and in vivo exogenous cholesterol localization A Latency to fall (seconds) from an accelerating rotarod at 10 weeks of age (3 weeks after cholesterol infusion) in wt ( N = 11); wt ACSF ( N = 11) and wt chol-high ( N = 7) mice. B-E Global motor activity (B), total distance travelled (C), mean velocity (D), and stereotyped movements (E) in an open field at 11 weeks of age (4 weeks after cholesterol infusion) (wt = 11; wt ACSF = 10; wt chol-high = 7). F Discrimination index (%) in the novel object recognition test of wt, wt ACSF, and wt chol-high mice at 11 weeks of age (4 weeks after cholesterol infusion) (wt = 11; wt ACSF = 10; wt chol-high = 7). DI above zero indicates a preference for the novel object; DI below zero indicates a preference for the familiar object. G, H Cholesterol content in the infused striatum (G) and ipsilateral cortex (H) of wt ACSF ( N = 3), wt chol-low ( N = 5), and wt chol-high ( N = 4) mice at 12 weeks of age after 4-week striatal cholesterol infusion. I-M Representative confocal images showing co-localization of BODIPY-chol (green) and TGN46 (I), calnexin (J), Rab9 (K), PMCA-ATPase (L), and LAMP1 (M) (red) in the striatum of R6/2 mice infused with BODIPY-cholesterol. Scale bars: 5 mum. Data information: The data in (A-H) are shown as scatterplot graphs with means +- standard error. Each dot corresponds to the value obtained from each animal.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 2 Expression of PMCA isoforms in multiple pancreatic cell lines. ( A ) Representative Western immunoblot showing the relative protein expression of total/pan-PMCA and PMCA isoform 1-4 in pancreatic cancer (MIA PaCa-2 and PANC-1) and non-malignant pancreatic cells (human pancreatic ductal epithelial (HPDE) and human pancreatic stellate cells (hPSC)). Mouse brain lysate was used as a positive control for PMCA expressions and beta-Actin was used as a protein loading control. ( B ) PMCA4 protein expression in each cell line was quantified from Western blot bands and normalized to beta-Actin housekeeping protein. ( C ) The relative expressions of ATP2B1-4 (PMCA1-4 mRNA) in each cell line were quantified by RT-qPCR. Data are expressed as relative mRNA expression normalized to corresponding S18 rRNA controls (2 -DeltaCtau ). Statistical comparisons were made using the Kruskal-Wallis test with Dunn's multiple comparison test and two-way analysis of variance (ANOVA) with Dunnett's multiple comparison test. Data are expressed as mean +- SEM. (n = 4-5, 4 replicates per treatment condition). * represents statistical significance where p < 0.05.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 3--figure supplement 1. Solubility of selected MLH1 variants. Transfected cells, either untreated (-) or treated for 16 hr with 10 muM bortezomib (+BZ) were lysed by sonication and immediately separated into supernatant ( S ) and pellet ( P ) fractions by centrifugation. Western blotting using antibodies to MLH1 was employed to determine the amount of MLH1 in the fractions. Blotting with antibodies to GAPDH and PMCA served as loading controls for the soluble and insoluble fraction, respectively.